MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, PSNL made $14,495,000 in revenue. -$21,652,000 in net income. Net profit margin of -149.38%.

Income Overview

Revenue
$14,495,000
Net Income
-$21,652,000
Net Profit Margin
-149.38%
EPS
-$0.24
Unit: Dollar
Revenue Breakdown
    • Pharma Tests And Services
    • Enterprise Sales
    • Clinical Diagnostic
    • Others

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Revenue
14,495,000 17,203,000 20,605,000 19,635,000
Cost of revenue
12,581,000 12,447,000 13,398,000 13,608,333.333
Research and development
12,171,000 12,381,000 12,640,000 12,407,333.333
Selling, general and administrative
13,034,000 14,179,000 12,263,000 11,581,000
Total costs and expenses
37,786,000 39,007,000 38,301,000 37,596,666.667
Loss from operations
-23,291,000 -21,804,000 -17,696,000 -17,961,666.667
Interest income
1,680,000 1,878,000 2,027,000 1,375,333.333
Interest expense
64,000 48,000 28,000 5,666.667
Other income (expense), net
26,000 -80,000 -46,000 2,532,000
Loss before income taxes
-21,649,000 -20,054,000 -15,743,000 -14,060,000
Provision for income taxes
3,000 2,000 7,000 5,000
Net loss
-21,652,000 -20,056,000 -15,750,000 -14,065,000
Earnings per share basic
-0.24 -0.23 -0.18 -0.243
Earnings per share diluted
-0.24 -0.23 -0.18 -0.243
Weighted average number of diluted shares outstanding
88,699,131 88,517,498 87,463,885 -600,112.333
Weighted average number of shares outstanding basic
88,699,131 88,517,498 87,463,885 -600,112.333
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$21,652,000 Provision for income taxes$3,000 Loss before incometaxes-$21,649,000 Other income(expense), net$26,000 Interest income$1,680,000 Other$90,000 Clinical Diagnostic$384,000 Population Sequencing$234,000 Enterprise Sales$650,000 Pharma Tests AndServices$13,137,000 Interest expense$64,000 Loss from operations-$23,291,000 Revenue$14,495,000 Total costs andexpenses$37,786,000 Selling, general andadministrative$13,034,000 Research and development$12,171,000 Cost of revenue$12,581,000

Personalis, Inc. (PSNL)

Personalis, Inc. (PSNL)